Patent ID: 8568995

Claim:
A method of predicting risk of coronary artery disease (CAD) in a subject comprising: (a) providing a modified low density lipoprotein-immune complex (mod-LDL-IC)-containing sample from said subject; (b) measuring oxidized-LDL immune complexes (ox-LDL-IC) and/or advanced glycation endproduct-LDL immune complexes (AGE-LDL-IC) in said sample; (c) comparing the amount of ox-LDL-IC and/or AGE-LDL-IC in said sample to a normal standard; and (d) predicting that said subject is at risk of developing CAD where an elevated amount of ox-LDL-IC and/or AGE-LDL-IC as compared to said standard is observed, or predicting that said subject is at not risk of developing CAD based where an elevated amount of ox-LDL-IC and/or AGE-LDL-IC as compared to said standard is not observed.